EPT Fumarate: A Novel Therapeutic Agent for Mitochondrial Dysfunction
Mitochondrial dysfunction is a major contributor to a wide range of degenerative diseases. This impairment in mitochondrial function can lead to cellular stress, ultimately resulting in various pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating issue. EPT Fumarate functions by